IL167892A - Nucleic acid and protein entitled 24p4c12 and compositions containing the same and uses thereof - Google Patents
Nucleic acid and protein entitled 24p4c12 and compositions containing the same and uses thereofInfo
- Publication number
- IL167892A IL167892A IL167892A IL16789205A IL167892A IL 167892 A IL167892 A IL 167892A IL 167892 A IL167892 A IL 167892A IL 16789205 A IL16789205 A IL 16789205A IL 167892 A IL167892 A IL 167892A
- Authority
- IL
- Israel
- Prior art keywords
- protein
- cancer
- peptide
- antibody
- amino acid
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Marine Sciences & Fisheries (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2002/038264 WO2004050828A2 (fr) | 2002-11-27 | 2002-11-27 | Acide nucleique 24p4c12 et proteine correspondante utilises dans le traitement et la detection du cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
IL167892A true IL167892A (en) | 2012-06-28 |
Family
ID=32467113
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL167892A IL167892A (en) | 2002-11-27 | 2005-04-06 | Nucleic acid and protein entitled 24p4c12 and compositions containing the same and uses thereof |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1565200A4 (fr) |
JP (1) | JP2006508163A (fr) |
AU (3) | AU2002352976B2 (fr) |
CA (1) | CA2503346C (fr) |
IL (1) | IL167892A (fr) |
WO (1) | WO2004050828A2 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2424745T3 (es) * | 2007-09-07 | 2013-10-08 | Agensys, Inc. | Anticuerpos y moléculas relacionadas que se unen a las proteínas 24P4C12 |
AU2010229192A1 (en) * | 2009-03-06 | 2011-09-29 | Agensys, Inc. | Antibody drug conjugates (ADC) that bind to 24P4C12 proteins |
JP2013049646A (ja) * | 2011-08-30 | 2013-03-14 | Tokyo Medical Univ | 癌治療剤 |
US20180282383A1 (en) | 2015-10-02 | 2018-10-04 | University Of Copenhagen | Small molecules blocking histone reader domains |
WO2017132279A1 (fr) | 2016-01-25 | 2017-08-03 | Genentech, Inc. | Méthodes de dosage d'anticorps bispécifiques dépendants des lymphocytes t |
US20200188510A1 (en) * | 2017-04-28 | 2020-06-18 | Hoyu Co., Ltd. | Allergy antigen and epitope thereof |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
JPS6023084B2 (ja) | 1979-07-11 | 1985-06-05 | 味の素株式会社 | 代用血液 |
US4640835A (en) | 1981-10-30 | 1987-02-03 | Nippon Chemiphar Company, Ltd. | Plasminogen activator derivatives |
US4722848A (en) | 1982-12-08 | 1988-02-02 | Health Research, Incorporated | Method for immunizing animals with synthetically modified vaccinia virus |
US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
US4496689A (en) | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
US5019369A (en) | 1984-10-22 | 1991-05-28 | Vestar, Inc. | Method of targeting tumors in humans |
EP0206448B1 (fr) | 1985-06-19 | 1990-11-14 | Ajinomoto Co., Inc. | Hémoglobine liée à un poly(oxyde d'alkylène) |
US4791192A (en) | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
US5225538A (en) | 1989-02-23 | 1993-07-06 | Genentech, Inc. | Lymphocyte homing receptor/immunoglobulin fusion proteins |
US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
ATE157012T1 (de) | 1989-11-03 | 1997-09-15 | Univ Vanderbilt | Verfahren zur in vivo-verabreichung von funktionsfähigen fremden genen |
US5279833A (en) | 1990-04-04 | 1994-01-18 | Yale University | Liposomal transfection of nucleic acids into animal cells |
US5204253A (en) | 1990-05-29 | 1993-04-20 | E. I. Du Pont De Nemours And Company | Method and apparatus for introducing biological substances into living cells |
SE9002480D0 (sv) | 1990-07-23 | 1990-07-23 | Hans Lilja | Assay of free and complexed prostate-specific antigen |
WO1993025673A1 (fr) | 1992-06-04 | 1993-12-23 | The Regents Of The University Of California | Therapie genique in vivo a l'aide d'une sequence significative sans intron |
US5804566A (en) | 1993-08-26 | 1998-09-08 | The Regents Of The University Of California | Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides |
US5679647A (en) | 1993-08-26 | 1997-10-21 | The Regents Of The University Of California | Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
PT735893E (pt) | 1993-09-14 | 2009-03-06 | Pharmexa Inc | Péptidos que se ligam aos alelos pan dr para aumentar a resposta imunitária |
US5739118A (en) | 1994-04-01 | 1998-04-14 | Apollon, Inc. | Compositions and methods for delivery of genetic material |
US5919652A (en) | 1994-11-09 | 1999-07-06 | The Regents Of The University Of California | Nucleic acid molecules comprising the prostate specific antigen (PSA) promoter and uses thereof |
US5736524A (en) | 1994-11-14 | 1998-04-07 | Merck & Co.,. Inc. | Polynucleotide tuberculosis vaccine |
US5962428A (en) | 1995-03-30 | 1999-10-05 | Apollon, Inc. | Compositions and methods for delivery of genetic material |
US5922687A (en) | 1995-05-04 | 1999-07-13 | Board Of Trustees Of The Leland Stanford Junior University | Intracellular delivery of nucleic acids using pressure |
CU22559A1 (es) | 1996-01-17 | 1999-05-03 | Ct Ingenieria Genetica Biotech | Sistema de expresión de antígenos heterologos en e. coli como proteínas de fusión |
ES2367640T3 (es) | 1996-03-11 | 2011-11-07 | Epimmune Inc. | Péptidos con afinidad de unión aumentada para al menos tres moléculas de tipo hla-a3. |
US6294378B1 (en) | 1996-07-26 | 2001-09-25 | Sloan-Kettering Institute For Cancer Research | Method and reagents for genetic immunization |
US5840501A (en) | 1996-10-25 | 1998-11-24 | Bayer Corporation | Determination of cPSA |
AU8555198A (en) * | 1997-08-01 | 1999-02-22 | Genset | 5' ests for secreted proteins expressed in prostate |
US6943235B1 (en) * | 1999-04-12 | 2005-09-13 | Agensys, Inc. | Transmembrane protein expressed in prostate cancer |
CA2369413C (fr) * | 1999-04-12 | 2013-07-09 | Agensys, Inc. | Proteine transmembranaire exprimee dans le cancer de la prostate et d'autres cancers |
EP1257578A2 (fr) * | 1999-12-23 | 2002-11-20 | Incyte Genomics, Inc. | Transporteurs et canaux ioniques |
-
2002
- 2002-11-27 EP EP02789937A patent/EP1565200A4/fr not_active Withdrawn
- 2002-11-27 CA CA2503346A patent/CA2503346C/fr not_active Expired - Lifetime
- 2002-11-27 JP JP2004557078A patent/JP2006508163A/ja active Pending
- 2002-11-27 WO PCT/US2002/038264 patent/WO2004050828A2/fr active Application Filing
- 2002-11-27 AU AU2002352976A patent/AU2002352976B2/en not_active Expired
-
2005
- 2005-04-06 IL IL167892A patent/IL167892A/en active IP Right Grant
-
2008
- 2008-02-08 AU AU2008200628A patent/AU2008200628B2/en not_active Expired
-
2009
- 2009-08-07 AU AU2009208065A patent/AU2009208065B2/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
JP2006508163A (ja) | 2006-03-09 |
AU2002352976B2 (en) | 2007-11-08 |
AU2008200628B2 (en) | 2009-05-07 |
WO2004050828A2 (fr) | 2004-06-17 |
WO2004050828A3 (fr) | 2004-12-09 |
CA2503346C (fr) | 2014-03-18 |
AU2009208065B2 (en) | 2012-05-24 |
EP1565200A2 (fr) | 2005-08-24 |
CA2503346A1 (fr) | 2004-06-17 |
AU2002352976A1 (en) | 2004-06-23 |
EP1565200A4 (fr) | 2009-06-24 |
AU2009208065A1 (en) | 2009-08-27 |
AU2008200628A1 (en) | 2008-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8426571B2 (en) | Nucleic acids and corresponding proteins entitled 202P5A5 useful in treatment and detection of cancer | |
US7226594B2 (en) | Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer | |
US8298776B2 (en) | Antibodies to tumor associated proteins | |
US7968090B2 (en) | Nucleic acids and corresponding proteins entitled 191P4D12(b) useful in treatment and detection of cancer | |
CA2481503A1 (fr) | Acide nucleique et proteine correspondante 98p4b6 utilises dans le traitement et la detection du cancer | |
AU2002361610A1 (en) | Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer | |
AU2009208065B2 (en) | Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer | |
EP2302041A1 (fr) | Acide nucléique et protéine correspondante intitulée 161P2F10B utile pour le traitement et la détection du cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed |